SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001178913-23-001535 from ELBIT SYSTEMS LTD (ESLT) (CIK 0001027664) (ESLT)

ELBIT SYSTEMS LTD (ESLT) (CIK 0001027664)
Date: April 26, 2023 · CIK: 0001027664 · Accession: 0001178913-23-001535

AI Filing Summary & Sentiment

File numbers found in text: 000-28998

Referenced dates: December 12, 2022, November 7, 2022

Date
April 26, 2023
Author
Not clearly detected
Form
CORRESP
Company
ELBIT SYSTEMS LTD (ESLT) (CIK 0001027664)

Letter

Confidential Treatment Requested by Elbit Systems Ltd.*

Elbit Systems Ltd. – PAGE E004

April 26, 2023

VIA EDGAR AND ELECTRONIC DELIVERY

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Manufacturing

100 F Street, N.E.

Washington, DC 20549 USA

Attention: Claire Erlanger

Kevin Woody

Re: ELBIT SYSTEMS LTD (the “Company”)

Form 20-F for the Year Ended December 31, 2021

File No. 000-28998

Reference is made to the letters dated November 7, 2022, December 13, 2022, February 14, 2023 and March 23, 2023 from the staff (the “Staff”) of the U.S. Securities and Exchange Commission (the “Commission”) to Elbit Systems Ltd. (the “Company”) with respect to the Company’s Form 20-F for the Fiscal Year Ended December 31, 2021, and the responses to such letters dated December 12, 2022, January 19, 2023, March 20, 2023 and April 4, 2023.

Further to discussions with the Staff regarding the aforementioned correspondence, the Company wishes to advise the Staff that it intends to add additional disclosures to the notes to the financial statements of its Form 20-F for the Fiscal Year Ended December 31, 2022, provided as Exhibit A to this letter.

If you have any questions or comments regarding these responses or require any additional information, please do not hesitate to contact me at kobi.kagan@elbitsystems.com.

Very truly yours,
ELBIT SYSTEMS LTD.

Show Raw Text
CORRESP
1
filename1.htm

      Confidential Treatment Requested by Elbit Systems Ltd.*

      Elbit Systems Ltd. – PAGE E004

    April 26, 2023

    VIA EDGAR AND ELECTRONIC DELIVERY

    U.S. Securities and Exchange Commission

    Division of Corporation Finance

    Office of Manufacturing

    100 F Street, N.E.

    Washington, DC 20549 USA

    Attention:          Claire Erlanger

                               Kevin Woody

    Re:          ELBIT SYSTEMS LTD (the “Company”)

    Form 20-F for the Year Ended December 31, 2021

    File No. 000-28998

    Reference is made to the letters dated November 7, 2022, December 13, 2022, February 14, 2023 and March 23,
      2023 from the staff (the “Staff”) of the U.S. Securities and Exchange Commission (the “Commission”) to Elbit Systems Ltd. (the “Company”) with respect to the Company’s Form 20-F for the Fiscal Year Ended December 31, 2021, and the responses to such
      letters dated December 12, 2022, January 19, 2023, March 20, 2023 and April 4, 2023.

    Further to discussions with the Staff regarding the aforementioned correspondence, the Company wishes to
      advise the Staff that it intends to add additional disclosures to the notes to the financial statements of its Form 20-F for the Fiscal Year Ended December 31, 2022, provided as Exhibit A to this letter.

    If you have any questions or comments
        regarding these responses or require any additional information, please do not hesitate to contact me at kobi.kagan@elbitsystems.com.

                Very truly yours,

                ELBIT SYSTEMS LTD.

                By:         /s/ Kobi Kagan

                Name:     Dr.
                    Kobi Kagan

                Title:        Executive Vice President and Chief Financial Officer

      * Due to the commercially sensitive nature of information contained in this letter, this submission is accompanied by the Company’s request for confidential treatment for selected portions of this
        letter, which have been replaced with the following placeholder “[***]” in the letter filed via EDGAR. The Company has filed a separate letter with the Office of Freedom of Information and Privacy Act Operations in connection with the confidential
        treatment request pursuant to Rule 83 of the Commission’s Rules on Information and Requests (17 C.F.R. § 200.83). The Company has also delivered a complete unredacted copy of the letter to its examiner at the Division of Corporation Finance.

      Elbit
          Systems Ltd.   Advanced Technology Center, P.O.B 539, Haifa 3100401, Israel

      Confidential Treatment Requested by Elbit Systems Ltd.

      Elbit Systems Ltd. – PAGE E005

        Exhibit A:  Proposed Additions to Financial Statement Note regarding Segments Disclosure in Form 20-F

    [***]

        Elbit
            Systems Ltd.   Advanced Technology Center, P.O.B 539, Haifa 3100401, Israel

        Confidential Treatment Requested by Elbit Systems Ltd.

        Elbit Systems Ltd. – PAGE E006

    [***]

        Elbit
            Systems Ltd.   Advanced Technology Center, P.O.B 539, Haifa 3100401, Israel

          Confidential Treatment Requested by Elbit Systems Ltd.

          Elbit Systems Ltd. – PAGE E007

      [***]

      Elbit
          Systems Ltd.   Advanced Technology Center, P.O.B 539, Haifa 3100401, Israel

            Confidential Treatment Requested by Elbit Systems Ltd.

            Elbit Systems Ltd. – PAGE E008

        [***]

        Elbit
            Systems Ltd.   Advanced Technology Center, P.O.B 539, Haifa 3100401, Israel

            Confidential Treatment Requested by Elbit Systems Ltd.

            Elbit Systems Ltd. – PAGE E009

        [***]

        Elbit
            Systems Ltd.   Advanced Technology Center, P.O.B 539, Haifa 3100401, Israel

            Confidential Treatment Requested by Elbit Systems Ltd.

            Elbit Systems Ltd. – PAGE E010

        [***]

        Elbit
            Systems Ltd.   Advanced Technology Center, P.O.B 539, Haifa 3100401, Israel